SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

GameStop is trending following an unsolicited fifty-six billion dollar acquisition bid for eBay, a move that has sparked intense debate among investors regarding the viability of such a highly leveraged acquisition. Community members are actively split, with some viewing the move as a visionary corporate chess play, while critics, including high-profile investors, have voiced significant concerns over the proposed debt levels and potential share dilution.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant institutional accumulation as investors position themselves ahead of major clinical readouts, including the upcoming 52-week data for its sonelokimab program. The community is focused on this data and the Goldman Sachs conference, with many speculating that these events could serve as the catalyst for an acquisition or a significant upward repricing.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is seeing significant investor interest as the community navigates a rotation into defensive value plays amidst broader market volatility. Discussions are heavily focused on the stock's role as a dividend-heavy ballast for long-term portfolios, while technical traders are closely monitoring key support levels and potential reversal signals for this consumer staples giant.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Papa John's International is trending as shareholders and analysts closely monitor the potential for the company to be taken private, fueled by recent buyout interest and frustration with current management. The community is actively debating the likelihood of a deal, the impact of various takeover bids, and the long-term strategic direction of the chain amidst ongoing operational challenges.

NVE Corp. engages in the development and sale of devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. It offers Isolators, sensors, and Power ICs. The company was founded by James M. Daughton in 1989 and is headquartered in Eden Prairie, MN.

NVE Corp

NVE Corp is attracting investor attention due to its unique position in the spintronics market, characterized by a small float, lack of debt, and a consistent dividend. The community is actively debating the company's growth potential within the expanding robotics and memory sectors, often drawing comparisons to other high-tech semiconductor plays.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as community members debate whether the assets rapid, leverage-driven ascent is a sustainable momentum play or a dangerous bubble tied to the South Korean semiconductor cycle. Traders are actively tracking shifts in the KOSPI index and local corporate news, weighing the risk of massive overnight swings against the potential for continued gains from the high-bandwidth memory shortage.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae $FNMA is trending as investors react to presidential comments regarding a potential IPO and a trillion-dollar valuation, fueling intense speculation about an end to the long-standing FHFA conservatorship. The community remains deeply divided between long-term holders anticipating a historic release and skeptics warning of potential market manipulation and delays.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is experiencing significant investor attention driven by speculation surrounding a potential strategic carve-out of its China operations and the company's recent shift toward profitable growth. Community discussion is heavily focused on the stock's low valuation relative to its brand reach, the anticipation of new product launches in the US, and the belief that JAB Holding's increased stake signals a long-term turnaround or acquisition play.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is currently a focal point for investors as the community discusses its potential for a major breakout, driven by the expanding 'agent economy' and significant infrastructure developments like the ASI Chain. Despite recent market volatility and its correlation with Bitcoin, holders remain highly bullish, citing strong fundamentals, institutional partnerships, and active accumulation by whales as reasons to view current price levels as a strategic entry point.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil is trending as traders debate the impact of escalating U.S.-Iran geopolitical tensions on crude supplies and the potential for a peace deal to disrupt market volatility. The community remains deeply divided, with discussions centered on whether to buy the dip during intermittent ceasefire negotiations or to short the instrument, citing concerns over leverage decay and the long-term sustainability of the current price rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Companys management team will participate in a...

Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder

Definium Therapeutics, Inc. (Nasdaq: DFTX) (Definium or the Company), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying...

Definium Therapeutics Announces New Employee Inducement Grants

Definium Therapeutics, Inc. (Definium or the Company), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric...

Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

Definium Therapeutics, Inc. (Definium or the Company) (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes...

Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EDT on Thursday, May...

Definium Therapeutics, Inc. (NASDAQ:DFTX) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Definium Therapeutics, Inc. (NASDAQ:DFTX - Get Free Report) have been given a consensus rating of "Buy" by the fifteen brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recom...

Definium Therapeutics, Inc. (NASDAQ:DFTX) Short Interest Update

Definium Therapeutics, Inc. (NASDAQ:DFTX - Get Free Report) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 9,819,886 shares, a decline of 35.1% from the March 31st total of 15,129,638 shares. Currently, 10.1% of...

Definium Therapeutics (NASDAQ:DFTX) Stock Price Down 6.7%  - Here's What Happened

Definium Therapeutics (NASDAQ:DFTX) Shares Down 6.7% - Here's What Happened...

Q1 Earnings Estimate for DFTX Issued By HC Wainwright

Definium Therapeutics, Inc. (NASDAQ:DFTX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2027 earnings estimates for shares of Definium Therapeutics in a report issued on...

Definium Therapeutics Investor Day: DT120 Phase III Readouts Set for Late Q2-Q3, PTSD Plan for 2027

Definium Therapeutics (NASDAQ:DFTX) used a company event to outline its late-stage development plans for DT120, an oral disintegrating tablet (ODT) formulation of LSD being studied for generalized anxiety disorder (GAD) and major depressive disorder (MDD), with an additional phase III study in post...

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

DFTXDefinium Therapeutics Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DFTX News